MWA
GSK icon

Medallion Wealth Advisors’s GSK GSK Stock Holding History

Medallion Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.86K Hold
88
– – ﹤0.01% 876
2025
Q4 		$4.32K Hold
88
– – ﹤0.01% 888
2025
Q3 		$3.8K Hold
88
– – ﹤0.01% 902
2025
Q2 		$3.43K Sell
88
-140
-61% -$5.35K ﹤0.01% 894
2025
Q1 		$8.63K Hold
228
– – ﹤0.01% 708
2024
Q4 		$7.71K Buy
+228
New +$8.21K ﹤0.01% 705

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Medallion Wealth Advisors's GSK Position: Q1 2026 in Review

Medallion Wealth Advisors held its GSK (GSK) position steady in Q1 2026 at 88 shares worth $4.86K. The position accounts for ﹤0.01% of the portfolio, ranked #876.

Medallion Wealth Advisors first reported a position in GSK in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.63K in Q1 2025. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Medallion Wealth Advisors held 88 shares of GSK worth $4.86K as of Q1 2026.
  • Medallion Wealth Advisors left its GSK share count unchanged in Q1 2026.
  • GSK made up ﹤0.01% of Medallion Wealth Advisors's portfolio in Q1 2026, its #876 holding.
  • Medallion Wealth Advisors first reported a position in GSK in Q4 2024 and has held it in 6 quarters since.
  • Medallion Wealth Advisors's GSK position peaked at $8.63K in Q1 2025.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Medallion Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.